Mylin Biotech Pvt Ltd
Association of hepatitis C virus infection and malnutrition– inflammation complex syndrome in maintenance hemodialysis patients
Gut microbiota and non-alcoholic fatty liver disease
Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis
Microbiota and the gut-liver axis: Bacterial translocation, inflammation and infection in cirrhosis
Protein energy malnutrition predicts complications in liver cirrhosis.
Muscle protein turnover and low-protein diets in patients with chronic kidney disease
Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy
p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin
Alterations of intestinal barrier and microbiota in chronic kidney disease
As we grow old: nutritional considerations for older patients on dialysis
The Kidney–Gut Axis: Implications for Nutrition Care
Protein-Bound Uremic Toxins from Gut Microbiota and Inflammatory Markers in Chronic Kidney Disease
Uremic toxins originating from colonic microbial metabolism
Gut Microbiota and Cardiovascular Uremic Toxicities
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes
Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial
The gut microbiota and the brain– gut–kidney axis in hypertension and chronic kidney disease
The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair
The Gut Microbiome, Kidney Disease, and Targeted Interventions
Cachexia and muscle wasting in cancer patients
The impact of malnutritional status on survival in elderly hemodialysis patients
